Barbara Klencke, M.D.
Board Member
TScan Therapeutics, Inc. (TCRX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Barbara Klencke, M.D.
Barbara Klencke, M.D. is recorded as Board Member at TScan Therapeutics, Inc. (TCRX). TScan Therapeutics, Inc. reported in an 8-K filed April 10, 2023 that Barbara Klencke, M.D. was appointed Class III director, effective April 6, 2023.
“On April 6, 2023, the Board of Directors (the "Board") of TScan Therapeutics, Inc. (the "Company") appointed Barbara Klencke, M.D., to the Board, effective April 6, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-04-06–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at TScan Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Gavin MacBeath CEO, CFO
- Stephen Biggar Chairman
- Jason A. Amello Chief Accounting Officer, Board Member
- Leiden Dworak Chief Accounting Officer
- Chrystal Louis Board Member
- Garry A. Nicholson Board Member
- Katina Dorton Board Member
- R. Keith Woods Board Member
- Zoran Zdraveski Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.